The Blackmores Limited (ASX:BKL) share price has been out of form in 2020. Are its shares in the buy zone yet?
The post Is the Blackmores (ASX:BKL) share price in the buy zone yet? appeared first on Motley Fool Australia. –
The Blackmores Limited (ASX: BKL) share price is on form for once on Monday.
In afternoon trade the health supplements company’s shares are up 1.5% to $70.15.
Despite this gain, the Blackmores share price is still down 27% from its 52-week high.
Is this a buying opportunity?
Although the Blackmores share price is trading notably lower this year, I wouldn’t be in a rush to invest just yet. This is due to its uncertain performance and the high multiples its shares are trading on.
This is a view that I share with analysts at Goldman Sachs. This morning the broker retained its neutral rating and cut its price target on Blackmores’ shares to $71.00.
It notes that the company is going through a major transformation at present.
Goldman explained: “BKL is progressing through a period of significant change as it vertically integrates production through its Braeside manufacturing facility, offloads underperforming assets (Global Therapeutics) and reestablishes its growth model into China and more broadly through Asia.”
This transformation is weighing on its earnings momentum and is expected to continue doing so in the near term.
However, based on the current Blackmores share price, Goldman suspects that the market is pricing in a much swifter turnaround.
It said: “Earnings momentum remains steadfastly negative, but growth expectations are strong and BKL’s PE remains elevated suggesting the market is pricing in a portion of a turnaround. We now forecast an underlying FY21 EBITDA of A$69.1mn and EPS of A$1.58.”
This means the Blackmores’ share price is trading at a lofty 44x FY 2021 earnings right now. And looking even further ahead, the broker is forecasting earnings per share of $2.21 in FY 2022. This equates to a multiple of 32x FY 2022 earnings for its shares.
In light of this, I would suggest investors either wait for a better entry point or for the company’s performance to improve.
In the meantime, I would sooner buy A2 Milk Company Ltd (ASX: A2M) shares. Goldman estimates that they are changing hands at 28x estimated FY 2021 earnings and 24x estimated FY 2022 earnings.
These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
- ASX 200 Weekly Wrap: ASX 200 snaps 4 week losing streak… just
- These were the best performing ASX 200 shares last week
- Why I’m watching the Blackmores (ASX: BKL) share price this year
- Half of ASX 200 stocks at risk as China-Australia relations hit new low
- ASX 200 Weekly Wrap: Earnings drag ASX back to reality
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.